Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03020472 · ClinicalTrials.gov registry record · Phase 4
Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age
A Phase 4 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT03020472: Clinical Trial Phase 4 study, sponsored by Stanford University.
NCT03020472 is a Phase 4 study that was terminated before completion, run by Stanford University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03020472, a Phase 4 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
This pilot study will investigate B-cell responses following vaccination with live, attenuated influenza vaccine (LAIV) in healthy children 2 years of age from blood samples taken at designated time points before and after vaccination.
Interventions
- BIOLOGICAL 2008-2009 FluMist LAIV (Intranasal)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03020472
The ClinicalTrials.gov registry entry for NCT03020472 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2008-2009 FluMist LAIV (Intranasal) is the first listed.
NCT03020472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03020472 about?
NCT03020472 is a clinical study titled "Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age". This pilot study will investigate B-cell responses following vaccination with live, attenuated influenza vaccine (LAIV) in healthy children 2 years of age from blood samples taken at designated time points before and after vaccination.
What is the current status of trial NCT03020472?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2008-11. Estimated completion is 2009-01.
What interventions are being tested in trial NCT03020472?
The interventions under investigation include: 2008-2009 FluMist LAIV (Intranasal) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03020472?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.